Rifaximin ameliorates intestinal inflammation in cirrhotic patients with hepatic encephalopathy

Rifaximin (RFX) treatment can attenuate not only hyperammonemia but also Enterococcus faecalis translocation and 10‐7G values, suggesting that RFX treatment may improve intestinal inflammation and result in better overall survival.[Image: see text]

Detalles Bibliográficos
Autores principales: Tamai, Yasuyuki, Iwasa, Motoh, Eguchi, Akiko, Shigefuku, Ryuta, Kamada, Yoshihiro, Miyoshi, Eiji, Takei, Yoshiyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Publishing Asia Pty Ltd 2021
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264230/
https://www.ncbi.nlm.nih.gov/pubmed/34263080
http://dx.doi.org/10.1002/jgh3.12596

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264230/
https://www.ncbi.nlm.nih.gov/pubmed/34263080
http://dx.doi.org/10.1002/jgh3.12596

Ejemplares similares